Latest issue of Clinical laboratory
November 2025
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
Biotech Fluidics expands range of flowmeters for real-time monitoring of liquid flow
, /in Product News /by panglobalBiotech Fluidics has expanded its family of non-invasive flowmeters for real-time monitoring of liquid flow. The range now includes four discrete devices optimized to operate from nano-litres per minute up to 650 millilitres per minute.
Olink’s new T48 Mouse Cytokine Panel enables deeper preclinical and translational disease research
, /in Product News /by panglobalOlink Holding has introduced their Olink Target 48 Mouse Cytokine Panel, a validated multiplexed protein panel that offers a detailed view of the murine immune system, enabling in-depth disease modelling, longitudinal studies and translational research.
Sphere Fluidics expands Cyto-Mine capabilities to meet cGMP requirements for drug manufacture workflows
, /in E-News /by panglobalSphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, has updated its flagship platform, Cyto-Mine, enabling it to be compliant with current Good Manufacturing Practice (cGMP) regulations enforced by the US FDA. By meeting these requirements, the company now provides a solution to increase efficiency and productivity of cell […]
CN Bio and LifeNet Health LifeSciences partner to supply validated primary human cells for micro-physiological systems
, /in E-News /by panglobalCN Bio, a leading Organ-on-a-Chip (OOC) company that designs and manufactures single-and multi-organ microphysiological systems (MPS), and LifeNet Health LifeSciences, a non-profit, global leader in human research solutions, will collaborate to supply validated primary human cells for use with CN Bio’s PhysioMimix OOC range of MPS. Under the agreement, LifeNet Health’s high-quality, MPS validated, hepatic […]
ISSCR introduces checklist to promote global best practices for human stem cell research
, /in E-News /by panglobalISSCR introduces checklist to promote global best practices for human stem cell research Recommendations from the Standards for Human Stem Cell Use in Research [1], published in June by the International Society for Stem Cell Research (ISSCR), include a publishing “checklist” that is now being used by laboratory scientists and implemented in the review process […]
Broken String Biosciences Closes $15M Series A Funding Round
, /in E-News /by panglobalBroken String Biosciences, a genomics company building a technology platform to drive the development of cell and gene therapies that are safer by design, has closed a US$15 million Series A investment round, co-led by Illumina Ventures and Mérieux Equity Partners, with contributions from HERAN Partners, and existing investors Tencent and Dieter von Holtzbrinck Ventures […]
Astrea Bio expands US manufacturing and warehousing capacity to cater to growing demand
, /in E-News /by panglobalAstrea Bioseparations will expand its manufacturing and warehousing capabilities in the US. The increased capacity reflects growing demand for the Company’s chromatography solutions in North American markets.
TherageniX awarded £995K grant to develop powdered gene therapy for bone regeneration
, /in E-News /by panglobalTherageniX, a University of Nottingham spin out pioneering a dry powder gene therapy formulation for bone graft augmentation, and its collaborator, the University of Nottingham, have been awarded a £995,000 grant from Innovate UK, the UK’s innovation agency. The funding will support the development of the company’s gene therapy in a powder, a non-viral gene delivery […]
MolGen appoints Hayden Jeffreys as Global Vice President of Sales & Marketing
, /in E-News /by panglobalMolGen, a global solutions provider of innovative DNA/RNA extraction and lab automation, has appointed Hayden Jeffreys as Global Vice President of Sales & Marketing.
Agilent Technologies sells Resolution Bioscience to Exact Sciences
, /in E-News /by panglobalAgilent Technologies will sell Resolution Bioscience to Exact Sciences, a leading provider of cancer screening and diagnostic tests. Financial terms of the agreement were not disclosed. Resolution Bioscience develops and commercializes next-generation sequencing-based precision oncology solutions. Agilent acquired the company in 2021.